Foresee doses first subject in Covid-19 ARDS treatment trial
Foresee Pharmaceuticals has started dosing patients in the Phase II/III clinical trial of its oral MMP-12 inhibitor, FP-025, to treat…

Foresee Pharmaceuticals has started dosing patients in the Phase II/III clinical trial of its oral MMP-12 inhibitor, FP-025, to treat…
Japanese company Shionogi has commenced Phase I/II clinical trial of a prophylactic Covid-19 vaccine candidate and administered the first dose.
Taiwanese biopharma company Golden Biotechnology (GoldenBiotech) has reported that data from its Phase IIa clinical study conducted in Russia showed…
Clinical research services provider Clinerion has partnered with PPC to offer Patient Network Explorer services in South Korea, China and…
Taiwan-based Lumosa Therapeutics is set to launch a Phase II proof of concept clinical trial to evaluate its drug candidate…
Chinese clinical-stage biopharmaceutical company I-Mab Biopharma and German biotech company MorphoSys have begun the first dosed Phase III clinical study…
TWi Biotechnology (TWiB) has completed patient enrolment in a Phase II clinical trial of AC-203 for the treatment of inherited…
Taiwan Liposome Company (TLC) has completed patient enrolment in a Phase I/II clinical trial of TLC590 following inguinal hernia repair…